# Chlorproguanil-Dapsone in Pregnant Women

> **NCT00126971** · PHASE1 · TERMINATED · sponsor: **Centers for Disease Control and Prevention** · enrollment: 132 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** chlorproguanil-dapsone

## Key facts

- **NCT ID:** NCT00126971
- **Lead sponsor:** Centers for Disease Control and Prevention
- **Sponsor class:** FED
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2025-04-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00126971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00126971, "Chlorproguanil-Dapsone in Pregnant Women". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT00126971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*